The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores

Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major

(2009) Anil Pathare et al.   ANNALS OF HEMATOLOGY

Efficacy of deferasirox in reducing and preventing cardiac iron overload in  -thalassemia

(2009) D. J. Pennell et al.   BLOOD

Deferasirox pharmacokinetics in patients with adequate versus inadequate response

(2009) D. Chirnomas et al.   BLOOD

Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload

(2009) Ali Taher et al.   BRITISH JOURNAL OF HAEMATOLOGY

Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

(2009) Kallistheni Farmaki et al.   BRITISH JOURNAL OF HAEMATOLOGY

Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major

(2009) P. Kirk et al.   CIRCULATION

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study

(2009) Ali Taher et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

(2008) Elliott Vichinsky et al.   ACTA HAEMATOLOGICA

Deferasirox in MDS patients with transfusion-caused iron overload—a phase-II study

(2008) Georgia Metzgeroth et al.   ANNALS OF HEMATOLOGY

Longitudinal analysis of heart and liver iron in thalassemia major

(2008) L. J. Noetzli et al.   BLOOD

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

(2008) Shahina Daar et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload

(2008) MD Cappellini et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effect of transfusional iron intake on response to chelation therapy in -thalassemia major

(2007) A. R. Cohen et al.   BLOOD